Prenatal Breast Pump Education of Mothers and Their Support Person

May 15, 2024 updated by: University of Florida

Prenatal Breast Pumping Education of Mothers and Their Support Person

The study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test whether antenatal education of the support person of mothers may decrease time to initiation of breast pumping, decrease time to lactogenesis stage II and increase breast milk production.

Study Overview

Detailed Description

Compelling evidence exists that breast milk helps protect premature infants from prematurity-specific morbidities, including feeding intolerance, late onset sepsis, and necrotizing enterocolitis. Unfortunately, mothers of VLBW infants often exhibit delayed lactogenesis stage II (when the milk "comes in") and inadequate breast milk production. Earlier initiation of breast milk expression following delivery is associated with increased lactation success. However, lack of nursing time and lack of hospital personal are significant barriers to the early initiation of milk expression in this population. The proposed study will follow a prospective cohort of racially and economically diverse mothers of premature infants for 3 weeks following delivery to test 1 primary aim and 1 secondary aim. Aim 1: will evaluate the feasibility of antenatal BM pumping education for SPs of mothers of preterm infants. Issues related to recruitment, randomization acceptance of the intervention, and refinement of the education materials and process will be scrutinized. Aim 2 will estimate variability of outcome measurements and effect sizes needed to calculate the sample size for a subsequent larger, adequately powered, randomized clinical trial. Eligible women and their SP will be randomly assigned to one of two groups. Group 1 will receive a prenatally delivered lactation educational program including video recordings, a demonstration of how the pump works and will have a breast pump available in their room. The volume of breast milk produced, timing of lactation stage II, duration of lactation and stress during initial expression will be measured. In addition, breast milk sodium levels will be analyzed on Day 1-7, Day 14 and 21.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Gainesville, Florida, United States, 32610
        • UF Health at the University of Florida

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • English speaking
  • stated intent to breastfeed
  • anticipating the birth of a premature infant < 35 weeks gestation.

Exclusion Criteria:

  • known illicit maternal drug use
  • history of breast reduction or augmentation
  • positive HIV status
  • infant not expected to live over 2 weeks following delivery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Antenatal Education Group
Patients will receive a prenatally delivered lactation educational program.
The support person (SP) of mothers at risk for preterm birth will be educated on how to use a breast pump and instructions regarding breast milk expression and have a pump in their hospital room
Other Names:
  • Antenatal Education
No Intervention: Standard of Care Group
Patients will receive standard of care and not a prenatally delivered lactation educational program.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Onset of Lactogenesis Stage II Through Volume Attainment
Time Frame: Up to 96 Hours
Time in hours until mothers pump at least 20 mL of milk in 2 consecutive pumping sessions
Up to 96 Hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast Milk Production on Day 1
Time Frame: 0-24 hours postpartum
Volume of breast milk produced from 0-24 hours postpartum
0-24 hours postpartum
Time to Breast Pumping Initiation
Time Frame: first 24 hours after delivery
Time to mothers beginning to pump breasts after delivery
first 24 hours after delivery
Breast Milk Production Day 2
Time Frame: Day 2 postpartum
Volume of breast milk produced on day 2 postpartum
Day 2 postpartum
Milk Production Day 3
Time Frame: 3 days postpartum
Volume of milk produced on Day 3 postpartum
3 days postpartum
Breast Milk Production Day 4
Time Frame: Day 4 postpartum
Volume of breast milk produced on Day 4 postpartum
Day 4 postpartum
Breast Milk Production on Day 5
Time Frame: Day 5 postpartum
Volume of breast milk produced on Day 5 postpartum
Day 5 postpartum
Breast Milk Production Day 6
Time Frame: Day 6 postpartum
Volume of breast milk produced on Day 6 postpartum
Day 6 postpartum
Breast Milk Production Day 7
Time Frame: Day 7 postpartum
Volume of milk produced on Day 7 postpartum
Day 7 postpartum
Breast Milk Production Day 14
Time Frame: Day 14 postpartum
Volume of breast milk produced on Day 14 postpartum
Day 14 postpartum
Breast Milk Production Day 21
Time Frame: 21 days postpartum
Volume of breast milk produced on Day 21 postpartum
21 days postpartum

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Leslie A Parker, University of Florida

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 6, 2018

Primary Completion (Actual)

May 4, 2022

Study Completion (Actual)

May 4, 2022

Study Registration Dates

First Submitted

July 1, 2019

First Submitted That Met QC Criteria

July 1, 2019

First Posted (Actual)

July 5, 2019

Study Record Updates

Last Update Posted (Actual)

May 21, 2024

Last Update Submitted That Met QC Criteria

May 15, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • P0081761
  • IRB201400318 (Other Identifier: University of Florida)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Preterm Birth

Clinical Trials on Prenatally Delivered Lactation Educational Program

Subscribe